DURVALUMAB
durvalumab 120 mg/2.4 mL injection, 2.4 mL vial
DURVALUMAB (15518R)
15518R
Manner of administration:Injection
Restriction
Indication: Resectable gastric and gastroesophageal junction adenocarcinoma
Treatment phase: Neoadjuvant treatment
Quantities & Cost
| Max amount | # of repeats | DPMA | Max safety net | General Patient Charge |
|---|---|---|---|---|
| Max amount: 1500 mg | # of repeats: 1 | DPMA: $10,854.88 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | ||||
| Imfinzi
(durvalumab 120 mg/2.4 mL injection, 2.4 mL vial)
|
||||
| Imfinzi
(durvalumab 500 mg/10 mL injection, 10 mL vial)
|
||||